“It is a privilege to help bring the advances of personalized medicine to our patients and physicians worldwide. At Genomic Health, our scientists have collaborated with many of the most talented research groups in the world and I take great pride in being able to provide our patients, physicians, and insurance providers with the data and confidence they require to make critical, rational, and individualized treatment decisions.”
Committed to expanding patient access to Genomic Health’s tests, Jim currently serves as Chief U.S. Commercial Officer. He oversees U.S. sales, marketing, reimbursement, and customer support efforts. Jim has led the U.S. marketing teams and portfolio planning for both near- and long-term strategy. From 2009 through 2012, Jim drove the expansion of Genomic Health’s international business efforts in Geneva, Switzerland. In Geneva, Jim and his team focused on collaborating with early adopting physicians in Canada, Ireland, Spain, Germany, and the UK to support broader Oncotype DX reimbursement and patient access. Prior to leading the marketing teams at Genomic Health, Jim worked in the managed care setting and led Genomic Health’s Western U.S. sales efforts from 2005 through 2008. Before joining Genomic Health, Jim was Vice President of Cerus Corporation, a biomedical products company, where he directed marketing and medical affairs. Prior to that appointment, Jim held a number of positions in sales, sales management, and marketing, including the role of Senior Director of Global Cox-2 Oncology Marketing at Pharmacia. Jim holds a Bachelor of Science in pharmacy from Creighton University and an M.B.A. from Kellogg School of Management, Northwestern University.
Oncotype DX My Colon Cancer Coach